Alkermes plc Net debt/EBITDA
¿Qué es el Net debt/EBITDA de Alkermes plc?
El Net debt/EBITDA de Alkermes plc es -4.53
¿Cuál es la definición de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Alkermes plc
¿Qué hace Alkermes plc?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Empresas con net debt/ebitda similar a Alkermes plc
- Silver Lake Resources tiene Net debt/EBITDA de -4.56
- Eros Resources tiene Net debt/EBITDA de -4.56
- Middlefield Banc tiene Net debt/EBITDA de -4.55
- Uranium Royalty tiene Net debt/EBITDA de -4.54
- Inscape tiene Net debt/EBITDA de -4.54
- Badger Meter tiene Net debt/EBITDA de -4.54
- Alkermes plc tiene Net debt/EBITDA de -4.53
- Takeaway.com NV tiene Net debt/EBITDA de -4.53
- Just Eat Takeaway.com N.V tiene Net debt/EBITDA de -4.53
- EMagin Corp tiene Net debt/EBITDA de -4.53
- Synopsys tiene Net debt/EBITDA de -4.52
- Anthem Inc tiene Net debt/EBITDA de -4.52
- Orthofix Medical Inc tiene Net debt/EBITDA de -4.52